Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Anadrol and Exemestane Interaction: Avoid | Peptide Database

Compound Profiles Anadrol Oral Anabolic Steroid | Extreme Mass & Strength Oxymetholone exerts its effects primarily through binding to the androgen receptor (AR) to promote protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it ca

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Anadrol

Oral Anabolic Steroid | Extreme Mass & Strength

Oxymetholone exerts its effects primarily through binding to the androgen receptor (AR) to promote protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme.

Exemestane

Steroidal Aromatase Inhibitor | Irreversible Estrogen Control

Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Anadrol with Exemestane?

Combining Anadrol with Exemestane is not recommended. Both Anadrol and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Anadrol and Exemestane safe together?

This combination carries significant risk. Both Anadrol and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Anadrol and Exemestane?

Both Anadrol and Exemestane carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 75% confidence and is inferred from pharmacological mechanism analysis.

How should I time Anadrol and Exemestane?

Anadrol has a half-life of ~8-9 hours and Exemestane has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Used as a diagnostic agent in Japan for assessing growth hormone deficiency in clinical settings. Stimulates endogenous growth hormone release through ghrelin receptor activation. Indirectly increases IGF-1 levels through enhanced GH secretion. Enhanced muscle protein synthesis through elevated growth hormone and IGF-1 levels. Improved lipolysis and body composition through GH-mediated fat oxidation. Faster recovery from exercise and improved sleep quality. Myoprotective effects in muscle atrophy models through GHS-R1a stimulation. Cytoprotective effects observed in cardiac tissue research.

Source: peptide-db.com ↗

Research Indications

The classic PCT SERM. Tamoxifen blocks estrogen negative feedback at the hypothalamus and pituitary, driving LH and FSH elevation to restart endogenous testosterone production after suppression from anabolic steroids or exogenous testosterone. Accelerates the return of serum testosterone to baseline levels following cycle cessation, reducing the duration of the hypogonadal window and associated symptoms such as fatigue, low libido, and muscle loss. Blocks estrogen receptor activation in breast tissue during aromatizable steroid cycles, preventing the development of gynecomastia without reducing systemic estrogen levels. Can reduce early-stage gynecomastia symptoms (tenderness, lump formation) by competitively blocking estrogen at the breast tissue receptor level. Less effective once fibrotic tissue has formed. FDA-approved for adjuvant treatment of estrogen receptor-positive breast cancer in both pre- and postmenopausal women. Reduces recurrence rates and mortality when used for 5-10 years following primary treatment. FDA-approved for chemoprevention in women at high risk of developing breast cancer. The NSABP P-1 trial demonstrated a 49% reduction in invasive breast cancer incidence.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Standard administration route; allows precise dosing and rapid hormone stimulation. Gonadotropin stimulation 100-200mcg Single dose or 2-3x weekly SubQ Fertility support 0.4-1.0 nmol/kg (50-150mcg) As directed by physician SubQ (KP-54) Sexual function (clinical) 1 nmol/kg/h 75-minute IV infusion IV infusion

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides